Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

Healthcare Biotechnology
"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Sembiosys Genetics Inc. > Who needs a crystal ball
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by RE38on Feb 06, 2012 10:45am
109 Views
Post# 19494371

RE: Who needs a crystal ball

RE: Who needs a crystal ball

Wow, because it happened to you once, you'll think it'll happen again. What goes up must come down...except the other 50% of the time when it doesn't. The market has an appetite for these biotech stocks now thanks to EKG, much like the market appetite for SCG and FSW skyrocketed last year after INT. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities